Macromolecular interactions of [14C-ring]melphalan in blood
- 1 April 1982
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 31 (8) , 1615-1619
- https://doi.org/10.1016/0006-2952(82)90389-6
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Erythrocytotoxicity Induced by Cancer Chemotherapeutic AgentsScandinavian Journal of Haematology, 1981
- Quantitative analysis of melphalan and its major hydrolysate in patients and animals by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Oral melphalan kineticsClinical Pharmacology & Therapeutics, 1979
- Reactions of the trifunctional nitrogen mustard tris(2-chloroethyl)-amine (HN3) with human erythrocyte membranes in vitroBiochemical Pharmacology, 1979
- Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant diseasePublished by Elsevier ,1978
- L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast CancerNew England Journal of Medicine, 1975
- Liver injury following halothane anesthesia in phenobarbital-pretreated ratsBiochemical Pharmacology, 1974
- Adsorption to human red blood cells of chlorambucil and other biological alkylating agentsBiochemical Pharmacology, 1969
- Melphalan (Alkeran®) Erythrocyte Agglutinin and Hemolytic AnemiaAnnals of Internal Medicine, 1967
- The Distribution of Radioactivity in Tissues of the Rat Following the Administration of a Nitrogen Mustard DerivativeBritish Journal of Cancer, 1957